841 filings
Page 9 of 43
DFRN14A
ok3zl n1srrwgm
6 Oct 21
Revised proxy by non-management
12:00am
CORRESP
6t0281okatoy9 u0d0qz
6 Oct 21
Correspondence with SEC
12:00am
CORRESP
cx7u7wpbvcd71ir
5 Oct 21
Correspondence with SEC
12:00am
DFAN14A
9edboq
4 Oct 21
Additional proxy materials by non-management
9:36am
CORRESP
d55 wuq5j3qpdl1u
4 Oct 21
Correspondence with SEC
12:00am
DFAN14A
t0vghmu5nd4aqvaplij8
30 Sep 21
Additional proxy materials by non-management
9:30am
8-K
l11q24j0 ogf
29 Sep 21
Unregistered Sales of Equity Securities
5:15pm
DEFA14A
5i2fkg1xk59j1vuj2i
29 Sep 21
Additional proxy soliciting materials
6:08am
8-K
ps8j18mndhs
29 Sep 21
Company is Successfully Executing on Multi-Faceted Strategy to Bring Leronlimab to Market
6:05am
DFAN14A
4b1lfnv 1nz9uek
28 Sep 21
Additional proxy materials by non-management
10:01am
PREC14A
vb5lr a31cefqsiu5i
24 Sep 21
Preliminary proxy with contested solicitation
5:31pm
DFAN14A
uhhwk2m
24 Sep 21
Additional proxy materials by non-management
10:10am
DEFA14A
pfsnry38k ins8cwgr
22 Sep 21
Additional proxy soliciting materials
4:07pm
8-K
6p48trdk
22 Sep 21
Other Events
4:05pm
DEFA14A
7pgi325exf5h
21 Sep 21
Additional proxy soliciting materials
9:30am
8-K
16trrl94r9fjt9ss7i
21 Sep 21
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021
9:29am
DEFA14A
s8u1ur3sh uvqwhg8ih9
20 Sep 21
Additional proxy soliciting materials
4:03pm
8-K
c3n pzbtriuvsz2
20 Sep 21
CytoDyn Announces Resolution of Federal Litigation with Rosenbaum/Patterson Activist Group
4:01pm
DFAN14A
xb2 j2yt42b0x0b
20 Sep 21
Additional proxy materials by non-management
2:24pm